WHO ICTRP trial

Australian Immunity Trial (Trial B): The effect of milk proteins on immune…

ACTRN12622000757718 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12622000757718
Public title Australian Immunity Trial (Trial B): The effect of milk proteins on immune function in healthy young adults
Scientific title Effect of milk containing only a2 beta-casein protein on immunity and inflammatory markers, gastrointestinal function, and cognitive function as compared to conventional milk which contains a2 and a1 beta-casein, in healthy young adults.
Primary sponsor Nutrition Research Australia
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Immune Function;Gastrointestinal Microbiome;Cognition; Immune Function Gastrointestinal Microbiome Cognition;Inflammatory and Immune System - Normal development and function of the immune system;Oral and Gastrointestinal - Normal oral and…
Interventions 250mL cow's milk containing A2/A2 beta-casein proteins. Milk will be consumed once per day for 14 days, with a 14-day run-in period, plus 14-day washout period. Participants will drink the milk as part of a test breakfast daily. Breakfast…
Registration date May 27, 2022
Target size 50
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations